Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon

BACKGROUND: Interferon is approved for adjuvant treatment of patients with stage IIB/III melanoma. The identification of predictive markers that would permit selection of patients would be beneficial. Specific human leukocyte antigen (HLA) class I and II antigens have previously shown an association...

Descripción completa

Detalles Bibliográficos
Autores principales: Gogas, Helen, Kirkwood, John M, Falk, Christine S, Dafni, Urania, Sondak, Vernon K, Tsoutsos, Dimosthenis, Stratigos, Alexandros, Markopoulos, Christos, Pectasides, Dimitrios, Spyropoulou-Vlachou, Maria
Formato: Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970916/
https://www.ncbi.nlm.nih.gov/pubmed/20549830
http://dx.doi.org/10.1002/cncr.25211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970916/
https://www.ncbi.nlm.nih.gov/pubmed/20549830
http://dx.doi.org/10.1002/cncr.25211

Ejemplares similares